行情

XXII

XXII

22ND CENTURY
AMEX

实时行情|Nasdaq Last Sale

3.350
-0.060
-1.76%
盘前: 3.430 +0.08 +2.39% 08:22 03/01 EST
开盘
3.500
昨收
3.410
最高
3.640
最低
3.310
成交量
215
成交额
--
52周最高
4.660
52周最低
0.5500
市值
4.65亿
市盈率(TTM)
-23.2639
分时
5日
1月
3月
1年
5年
新闻
财报
公告
公司事件
分析
简况
22nd Century Group首席执行官说,他们认为Co的当前股价“大大低估了我们的业务和非凡潜力的潜力”
22nd Century Group Provides Business Update Letter from CEO WILLIAMSVILLE, N.Y., Feb. 24, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE:XXII), a leading plant-based, biotechnology company that is focused on
Benzinga · 4天前
从2021年2月23日开始,大麻的涨跌幅
GAINERS: Rhinomed (OTCQB: RHNMF) shares closed up 19.94% at $0.10
Benzinga · 5天前
工业大麻市场规模,分享2021年全球行业趋势,细分,竞争对手战略,区域分析,回顾,主要参与者概况,到2024年的统计数据和增长分析
Feb 23, 2021 (The Expresswire) -- Global“Industrial Hemp Market” 2021 report consists of important factors such as the latest trends, performance drivers,...
The Express Wire · 6天前
星期二行业落后者:总承包商和建筑商,香烟和烟草库存
Feb 16, 2021 (MarketNewsVideo.com via COMTEX) -- In trading on Tuesday, general contractors & builders shares were relative laggards, down on the day by...
MarketNewsVideo.com · 02/16 17:02
22世纪集团股票上涨;共同授权美国专利,名为“ TRICHOME特殊促进剂,用于操纵毛发中的大麻素和其他化合物”
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220210040492%22.PGNR.&OS=DN/20210040492&RS=
Benzinga · 02/12 15:28
这可能是烟草和尼古丁的更安全替代品之一
Baystreet.ca · 02/03 14:00
按产品分列的戒烟和尼古丁消除瘾产品市场研究报告-到2025年的全球预测-COVID-19的累积影响
New York, Jan 29, 2021 (GLOBE NEWSWIRE via COMTEX) -- New York, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report...
GlobeNewswire · 01/29 10:59
22nd Century Group准备在获得FDA的销售授权后90天内推出VLK卷烟
-Reuters
Reuters · 01/11 17:03
更多
财务预测
每股收益每股净资产每股现金流
实际值(美元)
预测值(美元)
利润表更多
净利润营业总收入营业利润
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流投资现金流筹资现金流
经营现金流(美元)
同比(%)
了解XXII最新的财务预测,通过XXII每股收益,每股净资产,每股现金流等数据分析22ND CENTURY近期的经营情况,然后做出明智的投资选择。
分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测XXII价格均价为7.00,最高价位7.00,最低价为7.00。
EPS
机构持股
总机构数: 110
机构持股: 3,563.03万
持股比例: 25.66%
总股本: 1.39亿
类型机构数股数
增持
26
114.86万
建仓
10
1,115.84万
减持
24
72.62万
平仓
14
34.58万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
环保服务及设备
-1.40%
专业与商业服务
-0.46%
高管信息
Chairman/Director
Nora Sullivan
President/Chief Operating Officer
Michael Zercher
Chief Executive Officer
James Mish
Chief Financial Officer
John Franzino
Vice President
John Brodfuehrer
Vice President
Lisa Parks
Vice President - Research & Development
Juan Tamburrino
Director of Investor Relations
Mei Kuo
Independent Director
Michael Koganov
Independent Director
Roger O'Brien
Independent Director
Richard Sanders
  • 分红
  • 拆股
  • 内部人交易
暂无数据
XXII 简况
22nd Century Group, Inc. is a plant biotechnology company. The Company is focused on technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. It is engaged in various activities, including research and development of less harmful or modified risk tobacco products and tobacco plant varieties; development of X-22, a smoking cessation aid consisting of very low nicotine (VLN) cigarettes; manufacture, marketing and distribution of its RED SUN and MAGIC cigarettes; production of SPECTRUM research cigarettes for the National Institute on Drug Abuse (NIDA); contract manufacturing of third-party branded tobacco products, and research and development of plant varieties of hemp/cannabis, such as plants with low to no amounts of delta-9-tetrahydrocannabinol (THC), plants with high levels of cannabidiol (CBD), and other non-THC cannabinoids.

微牛提供22nd Century Group Inc(AMEX-XXII)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的XXII股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易XXII股票基本功能。